OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Child and Adolescent Psychopharmacology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Acknowledgment of Reviewers 2023	24
Pharmacogenetics in Child and Adolescent Psychiatry: Background and Evidence-Based Clinical Applications	24
Letter to the Editor: Delayed Fibrosis and Late Course Magnetic Resonance Imaging Findings in Clozapine-Induced Myocarditis in an Adolescent	22
Rosalind Franklin Society Proudly Announces the 2022 Award Recipient for Journal of Child and Adolescent Psychopharmacology	21
Child Mind Institute Summit: Telehealth and the Coronavirus	19
Letter to the Editor: Cannabidiol Treatment—Is There an Effect on Cognitive Functioning, Quality of Life, and Behavior? A Case Report	16
Letter to the Editor: Differences in Rate of Stimulant Medication Use for Attention-Deficit/Hyperactivity Disorder by Western and Non-Western Origins	16
Item Response Analyses of the Children's Depression Rating Scale-Revised Using Data from Clinical Studies	16
From the Editor-in-Chief's Desk	15
Letter: Mirtazapine-Associated Hyperkinetic Movements in a 17-Year-Old with Autism Spectrum Disorder and Chronic Catatonia: A Case Report	14
Probing the Neurodynamic Mechanisms of Cognitive Flexibility in Depressed Individuals with Autism Spectrum Disorder	13
The Aberrant Behavior Checklist for Fragile X Syndrome: A Qualitative Clinician Evaluation of Content Validity	11
From Consensus Statement to Pills to Pixels: New Innovations in Attention-Deficit/Hyperactivity Disorder Care	11
Comparing Symptoms of Major Depression in Youth with Confirmed Versus Suspected Bipolar Disorder	11
Methylphenidate Treatment Adherence and Persistence in Children in the Netherlands	11
Translating Attention-Deficit/Hyperactivity Disorder Rating Scale-5 and Weiss Functional Impairment Rating Scale-Parent Effectiveness Scores into Clinical Global Impressions Clinical Significance Leve	10
Efficacy of Preventing Relapse Evaluated by a Multicenter Randomized Double-Blind Placebo-Controlled Withdrawal Study of Escitalopram in Japanese Adolescents with Major Depressive Disorder	10
Program Evaluation to Aid Choice of Aripiprazole or Risperidone for Hospitalized Adolescents with Cannabis Use Disorder and Psychosis	10
Multivariable Prediction Modeling of Antidepressant Initiation in Unipolar Depressed Adolescents: A Secondary Analysis of the IMPACT Trial	9
From the Editor-in-Chief's Desk	9
Description, Implementation, and Efficacy of the Comprehensive Behavioral Intervention for Tics as First-Line Treatment for Tourette and Other Tic Disorders	9
Correction to: Machine Learning Identifies Smartwatch-Based Physiological Biomarker for Predicting Disruptive Behavior in Children: A Feasibility Study, by Romanowicz et al. J Child Adolesc	9
Clonazepam Treatment of Adolescent Catatonia in A Setting of Lorazepam-Related Hypotension	9
The Occurrence of Overweight and Obesity in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder According to Three Different Diagnostic Criteria for Obesity	9
Preliminary Observations of Resting-State Magnetoencephalography in Nonmedicated Children with Obsessive-Compulsive Disorder	9

A Long-Term, Open-Label Safety and Tolerability Study of Lisdexamfetamine Dimesylate in Children Aged 4–5 Years with Attention-Deficit/Hyperactivity Disorder	8
Psychotropic Medication Prescribing for Youth at a Regional Autism Center	8
Correction to: A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder, by Strawn et al. J Child Adolesc Psychopha	8
Letter to the Editor: Skin-Testing for Clones—Pediatric Obsessive Compulsive Disorder with Misidentification Syndrome	8
Pharmacological Treatment of Tourette Disorder in Children	8
Factors Associated with Symptom Persistence in PANS: Part II—Presenting Features, Medical Comorbidities, and IVIG Treatment History	7
Letter to the Editor: Aripiprazole-Induced Hypersexuality in an Autistic Child	7
Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors	7
Stimulant Patterns, Alone or with Other Psychotropic Classes, in Medicaid-Insured Youth Continuously Enrolled for 3–8 Years	7
Catatonic Symptoms Successfully Treated with Olanzapine in an Adolescent with Schizophrenia	7
Long-Term Safety and Efficacy of Blonanserin Oral Tablet in Adolescents with Schizophrenia: A 52-Week, Multicenter, Open-Label Extension Study	7
Efficacy and Safety of Dextroamphetamine Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results from a Pivotal Phase 2 Study	7
Clinical Use of Clozapine Serum Level and Management of Adverse Effects in an Adolescent with Difficult to Treat Schizophrenia	7
Parental Attitudes Toward Use of Ketamine in Adolescent Mood Disorders and Suicidality	6
Systematic Review and Meta-Analysis: Pharmacological and Nonpharmacological Interventions for Disruptive Mood Dysregulation Disorder	6
Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Journal of Child and Adolescent Psychopharmacology	6
Neurocognitive Outcomes from Memantine: A Pilot, Double-Blind, Placebo-Controlled Trial in Children with Autism Spectrum Disorder	6
Management of COVID-19 Infection-Associated Flare in an Adolescent with Pediatric Acute Neuropsychiatric Syndrome and Obsessive-Compulsive Disorder	6
A Short-Term Group Telehealth Cognitive Behavioral Therapy Intervention for Youth with Autism and Anxiety: A Pilot Study	5
High-Dose Benzodiazepines in Treatment of Malignant Catatonia in an Adolescent: Lorazepam, Clonazepam, and Differing Efficacy	5
Executive Functioning in Pediatric Anxiety and Its Relationship to Selective Serotonin Reuptake Inhibitor Treatment Response: A Double-Blind, Placebo-Controlled Trial	5
A Double-Blind Placebo-Controlled Pilot Study of Topiramate in Manic Adolescents Treated with Olanzapine	5
Investigating Predictors of Clozapine Response in Adolescents with Schizophrenia and Schizoaffective Disorder	5
Children's Relative Age and Medicine Treatment for Attention-Deficit/Hyperactivity Disorder Across Australian Jurisdictions with Different School Enrolment Policies	5
Antipsychotics in Inpatient Children and Adolescents with Seclusion and Restraint: A Preliminary Exploratory Retrospective Chart Review	5
From the Editor-in-Chief’s Desk: Gratitude for Mentors and Colleagues	5
Prevalence and Factors Affecting the Use of Antipsychotics and Antipsychotic Polypharmacy in a Child and Adolescent Psychiatry Inpatient Service	5
Monitoring of Adverse Drug Reaction-Related Parameters in Children, Youth, and Young Adults Prescribed Antipsychotic Drugs by General Practitioners	5
Serotonin Toxicity in Children and Adolescents: A Systematic Review and Meta-Analysis of Cases	5
Letter to the Editor: Liver Enzyme Elevation from Atomoxetine Use—A Case Report	4
Letter to the Editor: Edible Cannabis Use and Acute Psychotic Episode in an Adolescent	4
Incidence of Neuroleptic Malignant Syndrome During Antipsychotic Treatment in Children and Youth: A National Cohort Study	4
From the Editor-in-Chief's Desk	4
Seclusion-Induced Psychosis in an Adolescent Boy	4
Acknowledgment of Reviewers 2022	4
Adherence to Clinical Guidelines for Dose Finding and Monitoring Methylphenidate Use: A Medical Record Audit in Child and Adolescent Mental Health Care and Pediatric Settings	4
Medication Prescribing Patterns at a Youth Mental Health Service: A Single Center Retrospective Cross-sectional Study	4
From the Editor-in-Chief's Desk	4
A Novel Cognitive Training Program Targets Stimulus-Driven Attention to Alter Symptoms, Behavior, and Neural Circuitry in Pediatric Anxiety Disorders: Pilot Clinical Trial	4
From the Editor-in-Chief's Desk	4
Acknowledgment of Reviewers 2021	4
Pediatric Psychotropic Polypharmacy: An Evaluation of the Correlates and Prevalence Across Assessment Cycles in the National Health and Nutrition Examination Survey	4
From the Editor-in-Chief’s Desk: Harnessing Pharmacoepidemiology to Provide a Brighter Future for Children with Psychiatric Disorders	4
From the Editor-in-Chief's Desk	4
Effect of a Multilayer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Fixed-Dose, Placebo-Co	4
Differential Treatment Effects of Methylphenidate and Atomoxetine on Executive Functions in Children with Attention-Deficit/Hyperactivity Disorder	3
From the Editor-in-Chief's Desk: Advances in Patient-Centered Treatment for Attention-Deficit/Hyperactivity Disorder	3
An Investigation of Diversity in Childhood and Adolescent Antidepressant Studies: A Systematic Review	3
Letter to the Editor: The Impact of Adherence and CYP2C19 Phenotype on Escitalopram Exposure in Adolescents	3
Letter: Exploring the Relationship Between Smartphone Addiction, Psychological Distress, Stress, and Self-Esteem Among Moroccan High School Students: A Regression Equation Modeling Study	3

A National Pediatric Telepsychiatry Curriculum for Graduate Medical Education and Continuing Medical Education	3
From the Editor-in-Chief’s Desk: Keeping Our Eyes on The Ball and a Call for Discontinuation Research	3
Caregiver Burden, Stress, and Relationship Cohesion Among Self-Identified Caregivers of Children with Pediatric Acute-Onset Neuropsychiatric Syndrome	3
Psychotropic Polypharmacy Among Children and Youth with Autism: A Systematic Review	3
From the Editor-in-Chief’s Desk: Psychedelic Therapeutics—Something Old and Something New	3
Comparative Efficacy of Omega-3 Fatty Acid with Other Interventions for Depression in Children and Adolescents: A Systematic Review and Network Meta-Analysis	3
Neural Responses to Fluoxetine in Youths with Disruptive Behavior and Trauma Exposure: A Pilot Study	3
How Are Discrepant Parent–Child Reports Integrated? A Case of Depressed Adolescents	3
From the Editor-in-Chief's Desk	3
From the Editor-in-Chief's Desk: Reflecting on Our Past and Future	3
Navigating Pharmacological Treatment in an Adolescent with New Onset Psychosis: Clinical, Pharmacological, and Cultural Challenges	3
A Randomized, Double-Blind, Controlled Trial of Lithium Versus Quetiapine for the Treatment of Acute Mania in Youth with Early Course Bipolar Disorder	3
Agitation Management in a 5-Year-Old Boy with X Chromosome-Linked Monoamine Oxidase-A and Monoamine Oxidase-B Deficiency	3
Clozapine and Constipation: Considerations in an Obese Adolescent Girl	3
Safety Outcomes from a Long-Term, Prospective Study of Sertraline Use in Children and Adolescents: The Sertraline Pediatric Registry for the Evaluation of Safety	3
Exploring Risk Factors for Adverse Reactions in Children with an Acute Psychotic Episode Using the Global Trigger Tool: Does Age Matter?	3
What Is the Added Benefit of Combining Cognitive Behavioral Therapy and Selective Serotonin Reuptake Inhibitors in Youth with Obsessive Compulsive Disorder? A Bayesian Hierarchical Modeling Meta-Analy	3
New Onset Psychosis Complicated by Akathisia and Catatonia in the Context of Recent Immigration	3
Psychopharmacological Strategies Employing Guanfacine in an Adolescent Girl with Postural Orthostatic Tachycardia Syndrome and Severe Posttraumatic Stress Disorder	3
Screening for Depression in Adolescents with Developmental Disabilities: Brief Report	3
Low-Dose Olanzapine in the Treatment of Adolescents with Anorexia Nervosa: An Observational Naturalistic Case–Control Study	3
A Prepubertal Girl with Delusions of Pregnancy	3
From the Editor-in-Chief’s Desk: Special Issue on the Psychopharmacology of Neurodevelopmental Disorders	3
Effects of Long-Term Sertraline Use on Pediatric Growth and Development: The Sertraline Pediatric Registry for The Evaluation of Safety (SPRITES)	3
Evaluation of the Psychometric Properties of the Persian Version of Children's Depression Inventory in Iranian Adolescents	3